Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Rubrik (RBRK) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY27 EPS Guidance
Cardiovascular Systems (CSII) PT Raised to $20 at Stifel
February 9, 2023 8:07 AM ESTStifel analyst Mathew Blackman raised the price target on Cardiovascular Systems (NASDAQ: CSII) to $20.00 (from $18.00) while maintaining a Hold rating.... More
Lake Street Capital Markets Downgrades Cardiovascular Systems (CSII) to Sell
February 9, 2023 7:43 AM ESTLake Street Capital Markets analyst Brooks O'neil downgraded Cardiovascular Systems (NASDAQ: CSII) from Hold to Sell.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $13.31 yesterday.
... MoreAbbott (ABT) to acquire Cardiovascular Systems (CSII) for $20/share
February 9, 2023 6:22 AM ESTAbbott (NYSE: ABT) and Cardiovascular Systems, Inc. (NASDAQ: CSII), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.
CSI is a leader in devices for... More
Cardiovascular Systems (CSII) Misses Q2 EPS by 5c
February 9, 2023 4:50 AM ESTCardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.20), $0.05 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $61.5 million versus the consensus estimate of $63.06 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More